No Data
Prime Medicine Advances Gene Editing and Trials
Gene Editing Stocks Drop as Intellia Announces Layoffs
Prime Medicine to Present at 43rd Annual J.P. Morgan Healthcare Conference
Prime Medicine, Inc. (PRME): Is This Gene Therapy Stock a Good Buy Right Now?
We Think Prime Medicine (NASDAQ:PRME) Needs To Drive Business Growth Carefully
Express News | Prime Medicine Inc Files for Resale of up to 11 Mln Common Shares by the Selling Stockholder - SEC Filing
J L 7 2 : Master, hello. In your opinion, is this a good thing or a bad thing?
Trytosaveabit OP J L 7 2 : Good!
J L 7 2 Trytosaveabit OP : Thank you for your reply, I still hold a portion
Trytosaveabit OP J L 7 2 : You’re welcome! GL and big profits to ya
J L 7 2 Trytosaveabit OP : 大家一样都赚大钱